Raita Araki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Raita Araki has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Kazuhiro Noguchi
Kanazawa University Hospital
3 shared publications Rie Kuroda
Kanazawa University Hospital
3 shared publications- Toshihiro Fujiki
Department of Pediatrics, Kanazawa University, Kanazawa, Ishikawa, Japan
3 shared publications - Yasuhiro Ikawa
Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University 7 Department of Pediatrics School of Medicine Kanazawa
3 shared publications Hideaki Maeba
Kanazawa University
2 shared publicationsShintaro Mase
Kanazawa Univ
2 shared publications
Latest Publications
- Open Access
- 31 January 2024
- Published by Wiley
Presence of identical B-cell clone in both cerebrospinal fluid and tumor tissue in a patient with Opsoclonus-myoclonus syndrome associated with neuroblastoma
Opsoclonus-myoclonus syndrome associated with neuroblastoma (OMS-NB) is a refractory paraneoplastic syndrome which often remain neurological sequelae, and detailed pathogenesis has remained elusive. We encountered a pediatric patient with OMS-NB treated by immunosuppressed therapy who showed anti-glutamate receptor δ2 antibody and increased B-cells in cerebrospinal fluid (CSF), and multiple lymphoid follicles containing abundant B-cells in tumor tissue. Unbiased B-cell receptor repertoire analysis revealed identical B-cell clone was identified as the dominant clone in both CSF and tumor tissue. These identical B-cell clone may contribute to the pathogenesis of OMS-NB. Our results could facilitate the establishment of pathogenesis-based treatment strategies for OMS-NB.
- 31 January 2024
- Published by Wiley
Open AccessPresence of identical B-cell clone in both cerebrospinal fluid and tumor tissue in a patient with Opsoclonus-myoclonus syndrome associated with neuroblastoma
Opsoclonus-myoclonus syndrome associated with neuroblastoma (OMS-NB) is a refractory paraneoplastic syndrome which often remain neurological sequelae, and detailed pathogenesis has remained elusive. We encountered a pediatric patient with OMS-NB treated by immunosuppressed therapy who showed anti-glutamate receptor δ2 antibody and increased B-cells in cerebrospinal fluid (CSF), and multiple lymphoid follicles containing abundant B-cells in tumor tissue. Unbiased B-cell receptor repertoire analysis revealed identical B-cell clone was identified as the dominant clone in both CSF and tumor tissue. These identical B-cell clone may contribute to the pathogenesis of OMS-NB. Our results could facilitate the establishment of pathogenesis-based treatment strategies for OMS-NB.
- Open Access
- 25 November 2020
- Published by Wiley
High-dose methotrexate-induced acral erythema in two pediatric patients with acute lymphoblastic leukemia: a 17 pediatric case series of methotrexate induced acral erythema
High-dose methotrexate-induced acral erythema in two pediatric patients with acute lymphoblastic leukemia: a 17 pediatric case series of methotrexate induced acral erythemaKazuhiro Noguchi,1 Ryosei Nishimura,1* Yasuhiro Ikawa,1Shintaro Mase,1 Toshihiro Fujiki,1Rie Kuroda,1 Raita Araki,1 Hideaki Maeba,1 Akihiro Yachie1 and Taizo Wada1
- 25 November 2020
- Published by Wiley
Open AccessHigh-dose methotrexate-induced acral erythema in two pediatric patients with acute lymphoblastic leukemia: a 17 pediatric case series of methotrexate induced acral erythema
High-dose methotrexate-induced acral erythema in two pediatric patients with acute lymphoblastic leukemia: a 17 pediatric case series of methotrexate induced acral erythemaKazuhiro Noguchi,1 Ryosei Nishimura,1* Yasuhiro Ikawa,1Shintaro Mase,1 Toshihiro Fujiki,1Rie Kuroda,1 Raita Araki,1 Hideaki Maeba,1 Akihiro Yachie1 and Taizo Wada1